UA92011C2 - Облатка, содержащая стероидные гормоны - Google Patents

Облатка, содержащая стероидные гормоны

Info

Publication number
UA92011C2
UA92011C2 UAA200712054A UAA200712054A UA92011C2 UA 92011 C2 UA92011 C2 UA 92011C2 UA A200712054 A UAA200712054 A UA A200712054A UA A200712054 A UAA200712054 A UA A200712054A UA 92011 C2 UA92011 C2 UA 92011C2
Authority
UA
Ukraine
Prior art keywords
steroid hormones
delivery
blood
minutes
dissolves
Prior art date
Application number
UAA200712054A
Other languages
English (en)
Ukrainian (uk)
Inventor
Маркус Крумме
Альберт Радльмаер
Саша Генераль
Михаэль Диттген
Кейт Йенсен
Original Assignee
Лтс Ломанн Терапи-Зюстеме Аг
Баер Шеринг Фарма Акциенгезельшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36998911&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA92011(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Лтс Ломанн Терапи-Зюстеме Аг, Баер Шеринг Фарма Акциенгезельшафт filed Critical Лтс Ломанн Терапи-Зюстеме Аг
Publication of UA92011C2 publication Critical patent/UA92011C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к медицине, касается фармацевтической композиции в форме пленкоподобной системы для введения стероидных гормонов через слизистую оболочку. При этом описывается система высвобождения стероидных гормонов, которая растворяется в ротовой полости и высвобождает активное вещество с высокой биодоступностью. Пленкоподобная система высвобождения растворяется в ротовой полости преимущественно на протяжении времени меньше 30 минут, причем стероидный гормон, который высвобождается из системы высвобождения и через слизистую оболочку попадает в систему кровообращения, способствует быстрому повышению концентрации в крови.
UAA200712054A 2005-03-31 2006-03-15 Облатка, содержащая стероидные гормоны UA92011C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005015128A DE102005015128B4 (de) 2005-03-31 2005-03-31 Wafer enthaltend Steroidhormone

Publications (1)

Publication Number Publication Date
UA92011C2 true UA92011C2 (ru) 2010-09-27

Family

ID=36998911

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200712054A UA92011C2 (ru) 2005-03-31 2006-03-15 Облатка, содержащая стероидные гормоны

Country Status (26)

Country Link
US (2) US9763960B2 (ru)
EP (1) EP1863444B1 (ru)
JP (2) JP5843416B2 (ru)
KR (2) KR101428625B1 (ru)
CN (2) CN101132766A (ru)
AR (1) AR054245A1 (ru)
AU (1) AU2006228820B2 (ru)
BR (1) BRPI0609601A2 (ru)
CA (1) CA2598892C (ru)
CR (1) CR9468A (ru)
DE (1) DE102005015128B4 (ru)
DO (1) DOP2006000070A (ru)
EA (1) EA014183B1 (ru)
GT (1) GT200600126A (ru)
IL (1) IL186081A0 (ru)
MX (1) MX2007012081A (ru)
NO (1) NO20075404L (ru)
NZ (1) NZ592882A (ru)
PE (1) PE20061194A1 (ru)
SG (1) SG179459A1 (ru)
SV (1) SV2008002466A (ru)
TW (1) TWI393576B (ru)
UA (1) UA92011C2 (ru)
UY (1) UY29441A1 (ru)
WO (1) WO2006102990A2 (ru)
ZA (1) ZA200706116B (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2985026B1 (en) 2005-04-15 2022-08-03 Clarus Therapeutics, Inc. Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
US8492369B2 (en) 2010-04-12 2013-07-23 Clarus Therapeutics Inc Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
DE102006027796A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Estrogen-Gestagen-Kombinationen
JP2011511823A (ja) * 2008-02-13 2011-04-14 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト エストラジオール含有薬物の送達システム
MX2010008945A (es) * 2008-02-13 2010-09-07 Bayer Schering Pharma Ag Sistema de administracion de drogas con efecto estabilizante.
TW201008569A (en) * 2008-08-08 2010-03-01 Bayer Schering Pharma Ag Progestin-containing drug delivery system
CA2744127A1 (en) * 2008-11-21 2010-05-27 Bayer Schering Pharma Aktiengesellschaft Drug delivery system
DK3254676T3 (en) 2009-10-30 2019-03-11 Ix Biopharma Ltd QUICK-SOLVING SOLID DOSAGE FORM
US10806703B2 (en) * 2012-01-20 2020-10-20 Lts Lohmann Therapie-System Ag Transmucosal administration system for a pharmaceutical drug
US9822257B2 (en) 2012-07-23 2017-11-21 Crayola Llc Dissolvable films and methods of using the same
DE102017112527B4 (de) * 2017-06-07 2019-01-03 Lts Lohmann Therapie-Systeme Ag Schnell zerfallende Schaumwafer mit hohem Flächengewicht
MX2020008147A (es) * 2018-02-02 2020-10-28 Acerus Biopharma Inc Metodos de terapia de testosterona.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB981372A (en) * 1960-05-04 1965-01-27 Pfizer Ltd Pharmaceutical formulations for oral administration to animals
US4136162A (en) * 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
DE69312487T2 (de) * 1992-05-18 1997-11-27 Minnesota Mining & Mfg Einrichtung zur transmucosalen wirkstoffabgabe
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
DE19847252B4 (de) * 1998-10-02 2004-02-12 Jenapharm Gmbh & Co. Kg Bukkal applizierbare bioadhäsive Systeme mit zeitlich gesteuerter Wirkstofffreisetzung enthaltend Testosteronester und fakultativ zusätzlich Testosteron
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
US20030092658A1 (en) * 2001-02-02 2003-05-15 Meyers Rachel E. Novel human enzyme family members and uses thereof
CN1441669A (zh) * 2000-07-06 2003-09-10 德尔西斯药品公司 配制稳定性增强的保健产品的方法
GB0100760D0 (en) * 2001-01-11 2001-02-21 Biocompatibles Ltd Drug delivery from stents
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
FR2832311B1 (fr) * 2001-11-21 2004-04-16 Besins Int Belgique Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
JO2492B1 (en) * 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
US20050059645A1 (en) * 2003-07-31 2005-03-17 Bodor Nicholas S. Methods for the treatment of male and female sexual dysfunction
JP5619337B2 (ja) * 2003-10-10 2014-11-05 フェリング ビー．ブイ． 皮膚残渣を最小限に抑えるための経皮的医薬製剤

Also Published As

Publication number Publication date
DOP2006000070A (es) 2007-08-15
NO20075404L (no) 2007-12-20
JP2008534533A (ja) 2008-08-28
AU2006228820A1 (en) 2006-10-05
UY29441A1 (es) 2006-10-31
SV2008002466A (es) 2008-02-08
DE102005015128A1 (de) 2006-10-05
CN104983669B (zh) 2018-05-18
JP2013155190A (ja) 2013-08-15
AR054245A1 (es) 2007-06-13
KR20140063740A (ko) 2014-05-27
EA200702102A1 (ru) 2008-04-28
CA2598892C (en) 2014-10-14
CA2598892A1 (en) 2006-10-05
KR20080002798A (ko) 2008-01-04
DE102005015128B4 (de) 2008-12-11
MX2007012081A (es) 2007-11-21
EA014183B1 (ru) 2010-10-29
BRPI0609601A2 (pt) 2010-04-20
WO2006102990A2 (de) 2006-10-05
GT200600126A (es) 2007-03-14
TWI393576B (zh) 2013-04-21
JP5843416B2 (ja) 2016-01-13
TW200714299A (en) 2007-04-16
ZA200706116B (en) 2008-11-26
US9763960B2 (en) 2017-09-19
KR101428625B1 (ko) 2014-08-13
CN104983669A (zh) 2015-10-21
IL186081A0 (en) 2008-01-20
US20170348321A1 (en) 2017-12-07
CR9468A (es) 2008-01-21
EP1863444B1 (de) 2015-12-09
CN101132766A (zh) 2008-02-27
WO2006102990A3 (de) 2007-03-22
SG179459A1 (en) 2012-04-27
PE20061194A1 (es) 2006-11-23
US20060222708A1 (en) 2006-10-05
NZ592882A (en) 2012-12-21
AU2006228820B2 (en) 2011-08-25
EP1863444A2 (de) 2007-12-12

Similar Documents

Publication Publication Date Title
UA92011C2 (ru) Облатка, содержащая стероидные гормоны
MX2009002314A (es) Composiciones farmaceuticas que comprenden hgh para suministro oral.
PT1740154E (pt) Composições de insulina com absorção melhorada
DE602005010788D1 (de) Pharmazeutische Zusammensetzungen zur sicheren Verabreichung von bei der Behandlung von Drogenabhängigkeit verwendeten Arzneimitteln
TW200500098A (en) Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
HRP20060147B1 (hr) Terapijski sustav s kontroliranim otpuštanjem za nazalnu primjenu
TW200744665A (en) Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
WO2008099397A3 (en) Compositions and methods for enhancing transmucosal delivery
MX2010002409A (es) Composiciones y metodos para la distribucion de farmacos escasamente solubles.
IL179718A0 (en) Pharmaceutical composition containing irbesartan
WO2007016388A3 (en) Liquid formulations for controlled delivery of benzisoxazole derivatives
DK1883387T3 (da) Beholder til flydende medikamenter, der skal administreres
PL2131810T3 (pl) Podawanie doustne kalcytoniny
SE0200895D0 (sv) New pharmaceutical composition
WO2008087323A8 (fr) Forme galenique pour l'administration par voie trans-muqueuse de paracetamol
MX2010004556A (es) Formulacion farmaceutica de acido clavulanico.
GB2446341A (en) Method and system for transdermal drug delivery
IL179177A (en) A pharmaceutical product including acyclovir and delivery compound, dosage unit, use of acyclovir in the preparation of the pharmaceutical product, use of the pharmaceutical product in the preparation of a drug and a method for the preparation of the pharmaceutical product
TW200611697A (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
WO2003061557A3 (en) Levothyroxine pharmaceutical compositions, methods of making and methods of administration
MX2010008285A (es) Forma galenica para la administracion de triptanos por via trans-mucosa bucal.
WO2016014680A3 (en) Oral transmucosal compositions including aromatase inhibitors for low testosterone levels in men
WO2010120892A3 (en) Improved oral drug devices and drug formulations
WO2004014318A3 (en) Levothyroxine compositions and methods
WO2003013441A3 (en) Levothyroxine compositions and methods